Dr. Nancy T. Chang, biotech leader, joins Immix Biopharma board. Her leadership in XOLAIR® led to $5B+ in sales.Dr. Chang spearheaded the development of XOLAIR® from its creation to receiving FDA approval and successful commercialization. The sales of XOLAIR® have surpassed $5 billion to date.
